Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Antibiotic resistance in the intensive care unit
M. H. Kollef
,
V. J. Fraser
Institute of Clinical and Translational Sciences (ICTS)
Department of Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Siteman Cancer Center
COVID-19 Researchers
Division of Pulmonary & Critical Care Medicine
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Washington University School of Medicine
DBBS - Evolution, Ecology and Population Biology
Global Health Center (GHC)
Research output
:
Contribution to journal
›
Review article
›
peer-review
406
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antibiotic resistance in the intensive care unit'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Intensive Care Unit
100%
Antibiotic Resistance
100%
Antimicrobial Resistance
100%
Antibiotic Use
50%
Multidrug-resistant Pathogens
50%
Critically Ill Patients
25%
Effective Strategies
25%
Health Care Costs
25%
Treatment Plan
25%
Antimicrobial Therapy
25%
Convalescence
25%
Overall Health
25%
Multidisciplinary Approach
25%
Multidrug-resistant Infection
25%
Infection Control
25%
Bacterial Antibiotic Resistance
25%
Public Health Interventions
25%
Determinants of Outcome
25%
Prolonged Hospitalization
25%
Infection Control Practices
25%
New Antimicrobials
25%
Curb
25%
Unit Level
25%
Focus of Attention
25%
Antibiotic Failure
25%
Routine Treatment
25%
Seriously Ill Patients
25%
Confined Environment
25%
Nursing and Health Professions
Intensive Care Unit
100%
Antibiotic Resistance
100%
Antimicrobial Resistance
66%
Infection Control
33%
Infection
16%
Compliance
16%
Antibiotic Therapy
16%
Health Care Cost
16%
Antimicrobial Therapy
16%
Antiinfective Agent
16%
Treatment Failure
16%
Convalescence
16%
Nutrition Policy
16%
Medicine and Dentistry
Intensive Care Unit
100%
Antibiotic Resistance
100%
Pathogen
33%
Infection Control
33%
Health Care Cost
16%
Infection
16%
Antiinfective Agent
16%
Clinician
16%
Antibiotics
16%
Antibiotic Therapy
16%
Convalescence
16%
Public Health
16%
Antimicrobial Therapy
16%